Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2018	$ 4,000	$ 596,724		$ (3,842,186)	$ (3,241,462)
Balance, shares at Dec. 31, 2018	4,000,000
Stock-based compensation		121,226			121,226
Dividends on preferred stock		(221,279)			(221,279)
Net loss				(2,182,815)	(2,182,815)
Balance at Mar. 31, 2019	$ 4,000	496,671		(6,025,001)	(5,524,330)
Balance, shares at Mar. 31, 2019	4,000,000
Stock-based compensation		486,396			486,396
Dividends on preferred stock		(288,962)			(288,962)
Net loss				(2,186,920)	(2,186,920)
Balance at Jun. 30, 2019	$ 4,000	694,106		(8,211,921)	(7,513,815)
Balance, shares at Jun. 30, 2019	4,000,000
Balance at Dec. 31, 2019	$ 18,451	43,338,710		(15,712,414)	27,644,747
Balance, shares at Dec. 31, 2019	18,450,992
Issuance of common stock for accrued research and development expense	$ 221	1,131,792			1,132,013
Issuance of common stock for accrued research and development expense, Shares	220,666
Stock-based compensation		425,844			425,844
Foreign currency translation adjustment			(20,283)		(20,283)
Net loss				(3,797,198)	(3,797,198)
Balance at Mar. 31, 2020	$ 18,672	44,896,346	(20,283)	(19,509,612)	25,385,123
Balance, shares at Mar. 31, 2020	18,671,658
Stock-based compensation		295,356			295,356
Foreign currency translation adjustment			(19,208)		(19,208)
Net loss				(3,816,579)	(3,816,579)
Balance at Jun. 30, 2020	$ 18,672	$ 45,191,702	$ (39,491)	$ (23,326,191)	$ 21,844,692
Balance, shares at Jun. 30, 2020	18,671,658